Zobrazeno 1 - 10
of 144
pro vyhledávání: '"Yihebali Chi"'
Autor:
Jie Chen, Wenming Wu, Chunmei Bai, Yihebali Chi, Li Huo, Liming Jiang, Yuan Ji, Jie Luo, Jie Li, Jingnan Li, Wenhui Lou, Chenghao Shao, Lin Shen, Feng Wang, Yu Wang, Ling Xue, Jin Xu, Chunhui Yuan, Xianjun Yu, Xiaoyu Yin, Hong Zhao, Xiongzeng Zhu, Yupei Zhao
Publikováno v:
Journal of Pancreatology, Vol 7, Iss 2, Pp 97-105 (2024)
The World Health Organization (WHO) 2017 classifications for neuroendocrine neoplasms (NENs) subdivided grade 3 pancreatic neuroendocrine neoplasms (pNENs) into G3 well-differentiated pancreatic neuroendocrine tumors (G3 pNETs) and poorly differentia
Externí odkaz:
https://doaj.org/article/f421cf90587443f5bc5768b80042928d
Autor:
Yihebali Chi, Liming Jiang, Susheng Shi, Shun He, Chunmei Bai, Dan Cao, Jianqiang Cai, Qichen Chen, Xiao Chen, Yiqiao Deng, Shunda Du, Zhen Huang, Li Huo, Yuan Ji, Jie Li, Wenhui Lou, Jie Luo, Xueying Shi, Lijie Song, Bei Sun, Huangying Tan, Feng Wang, Xuan Wang, Zhewen Wei, Wenming Wu, Dianrong Xiu, Jianming Xu, Huadan Xue, Yi Yang, Fei Yin, Jiangyuan Yu, Chunhui Yuan, Yefan Zhang, Weixun Zhou, Dongbing Zhao, Hong Zhao
Publikováno v:
Journal of Pancreatology, Vol 6, Iss 4, Pp 139-150 (2023)
Many management strategies are available for pancreatic neuroendocrine neoplasms with liver metastases. However, a lack of biological, molecular, and genomic information and an absence of data from rigorous trials limit the validity of these strategi
Externí odkaz:
https://doaj.org/article/927be56a33384c70998585fbd3b94197
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background The mammalian target of rapamycin (mTOR) kinase, a central component of the PI3K/AKT/mTOR pathway, plays a critical role in tumor biology as an attractive therapeutic target. We conducted this first-in-human study to investigate t
Externí odkaz:
https://doaj.org/article/0116ecedf75541d9827069d3e5bddbc2
Autor:
Wen-Yang Liu, Jin-Ming Shi, Ning Li, Xin Wang, Yuan-Hong Gao, Yihebali Chi, Yong-Kun Sun, Qing Zhao, Yong-Jian Zhu, Hong-Da Chen, Hui Fang, Ning-Ning Lu, Shu-Nan Qi, Bo Chen, Shu-Lian Wang, Yong-Wen Song, Yue-Ping Liu, Ye-Xiong Li, Zheng Liu, Hai-Tao Zhou, Jian-Wei Liang, Xi-Shan Wang, Hai-Zeng Zhang, Yuan Tang, Jing Jin
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-9 (2022)
Abstract Purpose The safety of an MRI simulation-guided boost after short-course preoperative radiotherapy (SCPRT) for unresectable rectal cancer is assessed with a planned interim analysis. Methods and materials Patients diagnosed with clinical stag
Externí odkaz:
https://doaj.org/article/24f47fd0348e425abca5d10742769cf4
Autor:
Shu‐tao Ma, Ding‐yuan Wang, Yi‐bing Liu, Hui‐jing Tan, Yue‐yue Ge, Yihebali Chi, Bai‐lin Zhang
Publikováno v:
Cancer Medicine, Vol 11, Iss 13, Pp 2533-2540 (2022)
Abstract Background Primary neuroendocrine breast carcinomas (NEBCs) are an extremely rare and underrecognized subtype of mammalian carcinoma. The prognostic factors for NEBCs remain controversial. Methods In this multicenter retrospective study, the
Externí odkaz:
https://doaj.org/article/2b4362a4032e47ec9d3072b07a0de504
Autor:
Ning Li, Xiaoyong Xiang, Dongbin Zhao, Xin Wang, Yuan Tang, Yihebali Chi, Lin Yang, Liming Jiang, Jun Jiang, Jinming Shi, Wenyang Liu, Hui Fang, Yu Tang, Bo Chen, Ningning Lu, Hao Jing, Shunan Qi, Shulian Wang, Yueping Liu, Yongwen Song, Yexiong Li, Liyuan Zhang, Jing Jin
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Peri-operative chemo-radiotherapyplayed important rolein locally advanced gastric cancer. Whether preoperative strategy can improve the long-term prognosis compared with postoperative treatment is unclear. The study purpose to com
Externí odkaz:
https://doaj.org/article/f23c58f80c5442cfaabdc3fb755be685
Autor:
Yihebali Chi, Lijie Song, Weili Liu, Yuhong Zhou, Yadong Miao, Weijia Fang, Huangying Tan, Susheng Shi, Hai Jiang, Jianming Xu, Ru Jia, Bo Zheng, Liming Jiang, Jiuda Zhao, Rui Zhang, Huijing Tan, Yuehua Wang, Qichen Chen, Minjie Yang, Xi Guo, Zhou Tong, Zhirong Qi, Fuxing Zhao, Xiaofei Yan, Hong Zhao
Publikováno v:
EClinicalMedicine, Vol 54, Iss , Pp 101667- (2022)
Summary: Background: There are currently limited systemic treatment options for patients with advanced neuroendocrine tumours (NETS) and the efficacy of existing treatments is sub-optimal. We evaluated the efficacy and safety of Tegafur/gimeracil/ote
Externí odkaz:
https://doaj.org/article/f661b2745f404f9c816d0c1b758a1f4b
Autor:
Jingzhu Zhao, Yihebali Chi, Chuanxiang Hu, Xiaohong Chen, Minghua Ge, Yuan Zhang, Zhuming Guo, Jun Wang, Jie Chen, Jiewu Zhang, Ying Cheng, Zhendong Li, Hui Liu, Jianwu Qin, Jingqiang Zhu, Ruochuan Cheng, Zhengang Xu, Dapeng Li, Pingzhang Tang, Ming Gao, Xiangqian Zheng
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundMedullary thyroid carcinoma (MTC) is a rare type of thyroid cancer; however, it accounted for 13.4% of the disease-specific mortalities. ALTER01031 (NCT02586350) was a randomised, placebo-controlled phase 2b trial that evaluated the efficac
Externí odkaz:
https://doaj.org/article/71bbb6da655642cd96b735b8d222d403
The Chinese guidelines for the diagnosis and treatment of pancreatic neuroendocrine neoplasms (2020)
Autor:
Wenming Wu, Jie Chen, Chunmei Bai, Yihebali Chi, Yiqi Du, Shiting Feng, Li Huo, Yuxin Jiang, Jingnan Li, Wenhui Lou, Jie Luo, Chenghao Shao, Lin Shen, Feng Wang, Liwei Wang, Ou Wang, Yu Wang, Huanwen Wu, Xiaoping Xing, Jianming Xu, Huadan Xue, Ling Xue, Yang Yang, Xianjun Yu, Chunhui Yuan, Hong Zhao, Xiongzeng Zhu, Yupei Zhao, on behalf of the Chinese Pancreatic Surgery Association
Publikováno v:
Journal of Pancreatology, Vol 4, Iss 1, Pp 1-17 (2021)
Abstract. Pancreatic neuroendocrine neoplasms (pNENs) are highly heterogeneous, and the management of pNENs patients can be intractable. To address this challenge, an expert committee was established on behalf of the Chinese Pancreatic Surgery Associ
Externí odkaz:
https://doaj.org/article/b5a54e50fd534da281db3244f357a817
Autor:
Xin Wang, Dong-Bing Zhao, Lin Yang, Yihebali Chi, Hong Zhao, Li-Ming Jiang, Jun Jiang, Yuan Tang, Ning Li, Wen-Yang Liu, Li-Zhou Dou, Shuang-Mei Zou, Li-Yan Xue, Jian-Song Ren, Yan-Tao Tian, Xu Che, Chun-Guang Guo, Xiao-Feng Bai, Yue-Min Sun, Shu-Lian Wang, Yong-Wen Song, Yue-Ping Liu, Hui Fang, Ye-Xiong Li, Jing Jin
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveWe evaluated and compared the efficacy and safety of neoadjuvant chemoradiotherapy (NACRT) versus neoadjuvant chemotherapy (NACT) for locally advanced gastric cancer (LAGC) in a single-center randomized phase II trial.MethodsPatients with LA
Externí odkaz:
https://doaj.org/article/2c268c180ea148a1b65d98d9b2452660